Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1377330 | Bioorganic & Medicinal Chemistry Letters | 2008 | 5 Pages |
Abstract
This report describes replacement of the 4-(4-fluorophenyl)piperidine moiety in our CCR2 antagonists with 4-heteroaryl piperidine and 4-(carboxyphenyl)-piperidine subunits. Some of the resulting analogs retained potency in our CCR2 binding assay and had improved selectivity versus the IKr channel; poor selectivity against IKr had been a liability of earlier analogs in this series.
Graphical abstractThis report describes incorporation of 4-heteroaryl piperidine and 4-(carboxyphenyl)-piperidine subunits into our CCR2 antagonists, leading to new analogs retaining CCR2 potency, but with improved selectivity over IKr channel binding.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Alexander Pasternak, Stephen D. Goble, Pasquale P. Vicario, Jerry Di Salvo, Julia M. Ayala, Mary Struthers, Julie A. DeMartino, Sander G. Mills, Lihu Yang,